Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Centrillion Technologies is a life science company specializing in advanced genomic technologies and spatial transcriptomics. The company develops high-density DNA chips and the Delos platform, which allows for the high-resolution mapping of gene expression within the spatial context of biological tissues. Their products are designed to provide deeper insights into complex diseases, particularly in the fields of oncology and neuroscience, by enabling sub-cellular resolution analysis. Centrillion's technology integrates DNA sequencing with spatial information to overcome the limitations of traditional bulk or single-cell sequencing. Based in Palo Alto, California, the company maintains global operations including research and manufacturing facilities in Oregon and Taiwan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centrillion Technology Holdings.